Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences
Open accessThe DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index; 26 of the 102 sources its claims cite were checked for support.
Abstract
The prevalence of sarcopenic obesity is increasing worldwide, particularly amongst aging populations. Insulin resistance is the core mechanism of sarcopenic obesity and is also associated with variable cardiometabolic diseases such as cardiovascular disease, type 2 diabetes mellitus, and non-alcoholic fatty liver disease. Fat accumulation in muscle tissue promotes a proinflammatory cascade and oxidative stress, leading to mitochondrial dysfunction, impaired insulin signaling, and muscle atrophy. To compound the problem, decreased muscle mass aggravates insulin resistance. In addition, the crosstalk between myokines and adipokines leads to negative feedback, which in turn aggravates sarcopenic obesity and insulin resistance. In this review, we focus on the molecular mechanisms linking sarcopenic obesity and insulin resistance with various biological pathways. We also discuss the impact and mechanism of sarcopenic obesity and insulin resistance on cardiometabolic disease.
Overview
CoChat Summary
TL;DR
This narrative review argues that insulin resistance is the core mechanism linking sarcopenic obesity to cardiometabolic disease through fat accumulation, inflammation, mitochondrial dysfunction, and impaired insulin signaling in skeletal muscle. It further discusses how myokine–adipokine crosstalk and hormonal changes aggravate sarcopenic obesity and its cardiovascular, metabolic, and hepatic consequences.
Key findings
- Sarcopenic obesity is associated with a 2–3 times higher risk of functional disability than either sarcopenia or obesity alone, and it combines muscle loss with fat accumulation, including intramyocellular lipid, intermyocellular adipose tissue, and peri-muscular adipose tissue.
- In skeletal muscle, lipid intermediates such as DAG and ceramides activate PKC, JNK, IKK/NF-kB, and related pathways, causing serine/threonine phosphorylation of insulin receptor/IRS-1, impaired PI3K/Akt signaling, and reduced GLUT4 translocation; this impairs glucose uptake and promotes muscle atrophy.
- Inflammation is central: adipose tissue macrophage staining is approximately 10% in lean subjects but up to 50% in obese subjects, and proinflammatory cytokines such as TNF-α, IL-1β, and IL-6 contribute to insulin resistance, muscle atrophy, and cardiometabolic disease.
- Sarcopenic obesity and insulin resistance are linked clinically to atherosclerosis/cardiovascular disease, chronic heart failure, type 2 diabetes mellitus, metabolic syndrome, and NAFLD; skeletal muscle accounts for approximately 80–90% of postprandial glucose uptake, making muscle insulin resistance crucial in diabetes pathogenesis.
Methods
- Design: narrative review of molecular and clinical literature on sarcopenic obesity, insulin resistance, and cardiometabolic disease.
- Data/sample: no primary cohort or experimental sample; the paper synthesizes prior human, animal, and in vitro studies and cites clinical examples, including studies on carotid intima-media thickness, myocardial infarction, chronic heart failure, type 2 diabetes, metabolic syndrome, and NAFLD.
- Main analysis: thematic synthesis of mechanisms, including fat accumulation, inflammation, sex/growth hormone deficiency, skeletal muscle insulin signaling pathways, myocyte–adipocyte crosstalk, and pathophysiological links to cardiometabolic diseases.
Limitations
- The paper states that the definition of sarcopenic obesity has not been universally established and that different diagnostic criteria have different clinical implications.
- The paper repeatedly notes conflicting or insufficient evidence, including controversy over irisin and exercise, adiponectin’s clinical role, JAK/STAT signaling in muscle insulin resistance, and whether obesity itself is more predictive than sarcopenia for metabolic syndrome in some studies.
- Evident from the text: as a narrative review without a stated systematic search strategy, risk-of-bias assessment, or meta-analysis, it cannot quantify effect sizes or resolve heterogeneity across the cited studies.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
20 Valid · 4 Not valid · 62 Not checked · 9 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“A British regional health study reported that older subjects with sarcopenic obesity had the highest cardiovascular mortality [113].”
§ Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences > 4. Pathophysiological Link among Cardiometabolic Disease, Sarcopenic Obesity, and Insulin Resistance > 4.1. Atherosclerosis and Cardiovascular Disease
What the sources say
- Disputedcites [113] Atkins, 2014, Sarcopenic obesity and risk of cardiovascular disease and mortality: A population-based cohort study of older men, J. Am. Geriatr. Soc. sourceExperimental — accuracy not yet measured
Our copy (Abstract Conclusion; Discussion, and Discussion > Strengths and Limitations) states the opposite for cardiovascular mortality: 'Sarcopenic obese men had the highest risk of all-cause mortality but not CVD mortality,' and the Abstract Results add that CVD mortality risk was significantly greater in sarcopenic and obese but NOT sarcopenic obese men. The only point at which the sarcopenic obese group topped CVD mortality was the age-adjusted model, which lost significance after adjustment for lifestyle variables (Results). The highest-risk finding the paper reports for sarcopenic obesity is all-cause mortality (HR = 1.72, 95% CI = 1.35–2.18), so the claim substitutes CVD mortality for all-cause mortality; it also generalises 'older men' (British Regional Heart Study, aged 60–79) to 'older subjects'. (LLM, conf=0.85)
Checked by a reasoning model — may be wrong.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This complex disorder results in a 2–3 times higher risk of functional disability than either sarcopenia or obesity alone [14].”
§ Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences > 2. Sarcopenia and Sarcopenic Obesity > 2.1. Definition
What the sources say
- Partly supportedcites [14] Rolland, 2009, Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: The EPIDOS (EPIDemiologie de l’OSteoporose) Study, Am. J. Clin. Nutr. sourceExperimental — accuracy not yet measured
The Results (page unavailable) report roughly 2–3 times higher odds of difficulty with several physical tasks for sarcopenic-obese women than for purely sarcopenic women. Compared with purely obese women, however, the difference was statistically significant only for going down stairs. The study measured self-reported functional difficulties in a cross-sectional sample, not a general 2–3-fold higher risk of developing disability than either group. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Intermyocellular adipose tissue (IMAT) and IMCL secrete myostatin, CCL2, TNF-α, IL-1β, and IL-6, thus inducing IR and lipotoxicity, which is discussed in the next section [30].”
§ Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences > 2. Sarcopenia and Sarcopenic Obesity > 2.2. Molecular Mechanism of Sarcopenic Obesity
What the sources say
- Partly supportedcites [30] Rivas, 2016, Diminished anabolic signaling response to insulin induced by intramuscular lipid accumulation is associated with inflammation in aging but not obesity, Am. J. Physiol. Regul. Integr. Comp. Physiol. sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) links lipid accumulation in obesity to inflammation and secretion of TNF-α, IL-1β, and IL-6. It does not say that IMAT and IMCL themselves secrete those cytokines or myostatin and CCL2, nor does it establish that such secretion induces insulin resistance and lipotoxicity. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The amount of PMAT is correlated with the severity of muscle atrophy [31].”
§ Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences > 2. Sarcopenia and Sarcopenic Obesity > 2.2. Molecular Mechanism of Sarcopenic Obesity
What the sources say
- Supportedcites [31] Zhu, S., Tian, Z., Torigoe, D., Zhao, J., Xie, P., Sugizaki, T., Sato, M., Horiguchi, H., Terada, K., and Kadomatsu, T. (2019). Aging-and obesity-related peri-muscular adipose tissue accelerates muscle atrophy. PLoS ONE, 14. source
The Results section, “PMAT accumulation increases with muscle atrophy in aged mice,” reports that mice with at least 5% PMAT had lower muscle mass and muscle-fiber cross-sectional area than mice with less than 5% PMAT. The authors describe the degree of PMAT deposition as associated with progression of muscle atrophy in aged mice. (LLM, conf=0.92)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Low GH levels reduce IGF1 action by sequentially downregulating the PI3K-AKT/PKB-mTOR pathway, which induces protein synthesis in muscles [49].”
§ Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences > 2. Sarcopenia and Sarcopenic Obesity > 2.2. Molecular Mechanism of Sarcopenic Obesity
What the sources say
- Partly supportedcites [49] Egerman, 2014, Signaling pathways controlling skeletal muscle mass, Crit. Rev. Biochem. Mol. Biol. sourceExperimental — accuracy not yet measured
The section on IGF1/PI3K/Akt hypertrophy signaling (page not provided) describes IGF1 activating PI3K/Akt and mTORC1 signaling in skeletal muscle; its Figure 1 caption links that signaling to protein synthesis. The passages do not say that low growth hormone (GH) levels reduce IGF1 action or downregulate this pathway. (LLM, conf=0.86)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
43 more claims · 9 with their cited sources checked
Create a free account to see all 95 claims and to verify the 76 references still open.
- It may state two separate claims as one. 44
- Probably not a substantial claim. 5
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Various myokines released from active muscles act as signalling mediators between skeletal muscle and other vital organs, such as the liver, fat, and brain.[ 5 ]”
From Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review (2022) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Secondly, metabolic disorders including cardiometabolic syndrome (CMS), diabetes, cardiovascular disease (CVD), and cancer are common comorbidities of SO (54, 55).”
From Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments (2020) · cites this paper as [54]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Obesity can independently lead to loss of muscle mass and function, due to the negative impact of adipose tissue-dependent metabolic derangements, such as oxidative stress, in fl ammation, and insulin resistance, all which negatively affect muscle mass [6].”
From Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement (2022) · cites this paper as [6]
In the citing paper
“Aging-associated increases in visceral fat and reduced muscle mass are correlated with multiple adverse cardiometabolic effects and contribute to poor health outcomes (119).”
From Health Consequences of Sarcopenic Obesity: A Narrative Review (2020) · cites this paper as [119]
In the citing paper
“Obesity can independently lead to loss of muscle mass and function, due to the negative impact of adipose tissue-dependent metabolic derangements, such as oxidative stress, inflammation and insulin resistance, all of which negatively affect muscle mass [6].”
From Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement (2022) · cites this paper as [6]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818 · cited 3×
“EWGSOP2 [2] Use the SARC-F questionnaire to find subjects with sarcopenia Decreased muscle mass and Decreased muscle strength or performance NA”
BackgroundMethodObesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“In adipose tissue from lean subjects, approximately 10% of cells stained positive for macrophages, but in obese subjects, this number increased to up to 50% [38].”
BackgroundInflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773 · cited 1×
“Atherogenesis is a complicated process that includes oxidative stress, inflammation, endothelial dysfunction, vascular proliferation, and thrombosis [104].”
BackgroundIncreased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508 · cited 2×
“It causes the dysregulation of adipocytokines, such as adiponectin, PAI-1, IL-6, and MCP-1, leading to metabolic syndrome [134].”
BackgroundA PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
Boström, P., Wu, J., Jedrychowski, M. P., Korde, A., Ye, L., Lo, J. C., Rasbach, K. A., Boström, E. A., Choi, J. H., Long, J. Z., et al. (2012) · Nature · doi:10.1038/nature10777 · Cited by 4,810 · cited 1×
“Irisin is a PPARγ-coactivator-1α (PGCα)-dependent myokine that stimulates browning in subcutaneous adipose tissues and induces increased energy expenditure, which improves obesity and IR through the MAPK and ERK pathways [92,93].”
BackgroundYamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238 · cited 1×
“Thus, it facilitates insulin sensitivity by increasing glucose uptake in skeletal muscle and by stimulating fatty acid oxidation through activation of the 5′-AMP-activated protein kinase (AMPK) signaling pathway [100].”
BackgroundSarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia
Chen, L.-K., Liu, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Bahyah, K. S., Chou, M.-Y., Chen, L.-Y., Hsu, P.-S., Krairit, O., et al. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.11.025 · Cited by 4,051 · cited 3×
“Sarcopenia results in a decreased metabolic rate, low physical activity, and myokine deficiency, which collectively leads to the proinflammatory effect, and exacerbates obesity.”
BackgroundInfluentialSarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604 · cited 2×
“Moreover, obesity accompanies the accumulation of lipids in the liver, thus aggravating insulin resistance in hepatocytes [141].”
BackgroundA Novel Paradigm for Heart Failure With Preserved Ejection Fraction
Paulus, W. J., & Tschöpe, C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.092 · Cited by 3,564 · cited 1×
“Inflammation due to sarcopenic obesity results in reduced NO, cyclic guanosine monophosphate (cGMP), and protein kinase G (PKG) activity in cardiomyocytes, leading to LV hypertrophy and stiffness [120].”
BackgroundKim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Studenski, S. A., Peters, K. W., Alley, D. E., Cawthon, P. M., McLean, R. R., Harris, T. B., Ferrucci, L., Guralnik, J. M., Fragala, M. S., Kenny, A. M., et al. (2014) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glu010 · Cited by 2,545
Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
DeFronzo, R. A., & Tripathy, D. (2009) · Diabetes Care · doi:10.2337/dc09-s302 · Cited by 2,102
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078 · cited 1×
“IR is the main characteristic of NAFLD and is observed in the liver, skeletal muscle, and adipose tissue in sarcopenic obesity [140].”
BackgroundThe extended protein kinase C superfamily
MELLOR, H., & PARKER, P. J. (1998) · Biochemical Journal · doi:10.1042/bj3320281 · Cited by 1,538
The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
Samuel, V. T., & Shulman, G. I. (2016) · Journal of Clinical Investigation · doi:10.1172/jci77812 · Cited by 1,484 · cited 9×
“In genetic mouse models of muscle-specific IR, by deleting the IRTK [142] or GLUT4 [143] genes, hepatic steatosis and adiposity were increased [142].”
BackgroundInfluentialSarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies
Batsis, J. A., & Villareal, D. T. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0062-9 · Cited by 1,382 · cited 2×
“This body composition change brings unchanged or similar body weight or BMI; however, the change shifts toward unfavorable status, including reduced baseline metabolic rate, decreased mitochondrial number and volume, and increased oxidative stress, which exacerbates the vicious cycle [13].”
BackgroundSARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes
Malmstrom, T. K., Miller, D. K., Simonsick, E. M., Ferrucci, L., & Morley, J. E. (2016) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12048 · Cited by 1,155 · cited 1×
“The question comprises the subjects’ perception of his/ her limitations in strength, walking ability, rising from a chair, stair climbing, and experiences with falls [21].”
BackgroundCusi, K., Maezono, K., Osman, A., Pendergrass, M., Patti, M. E., Pratipanawatr, T., DeFronzo, R. A., Kahn, C. R., & Mandarino, L. J. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7535 · Cited by 1,139 · cited 9×
“MAPK Family JNK is a member of the MAPK family and is activated by TNF-α, IL-1β, free-fatty acids, ER stress, and LTB4 [66,67].”
BackgroundInfluentialAge-related and disease-related muscle loss: The effect of diabetes, obesity, and other diseases
Kalyani, R. R., Corriere, M., & Ferrucci, L. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70034-8 · Cited by 1,102 · cited 3×
“Hypogonadal status also contributes to sarcopenic obesity by increasing levels of TNF-α and IL-6, which leads to central obesity [11,47].”
BackgroundBody Composition in Healthy Aging
BAUMGARTNER, R. N. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06498.x · Cited by 1,078 · cited 1×
“New Mexico Aging Process Study [16] ASM/height2 < 7.”
BackgroundEllingsgaard, H., Hauselmann, I., Schuler, B., Habib, A. M., Baggio, L. L., Meier, D. T., Eppler, E., Bouzakri, K., Wueest, S., Muller, Y. D., et al. (2011) · Nature Medicine · doi:10.1038/nm.2513 · Cited by 922 · cited 1×
“In the pancreas, IL-6 stimulates insulin secretion by beta cells by upregulating glucagon-like peptide-1 (GLP-1) [85].”
BackgroundGrundy, S. M. (2016) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2015.10.004 · Cited by 882
Kalinkovich, A., & Livshits, G. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.008 · Cited by 882 · cited 2×
“An increase in oxidant compounds activates the stress pathways including IKK, JNK, and p38-MAPK [59].”
BackgroundKratz, M., Coats, B. R., Hisert, K. B., Hagman, D., Mutskov, V., Peris, E., Schoenfelt, K. Q., Kuzma, J. N., Larson, I., Billing, P. S., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.08.010 · Cited by 815 · cited 2×
“In obesity-induced activation of macrophages, CD38, CD319, and CD274, are derived from the cell surface and only approximately 5% of the cell surface protein expression patterns overlap [43].”
BackgroundGroop, L. C., Bonadonna, R. C., DelPrato, S., Ratheiser, K., Zyck, K., Ferrannini, E., & DeFronzo, R. A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114142 · Cited by 812 · cited 1×
“Imported glucose is stored as glycogen or enters the glycolytic pathway, and is either oxidized or released as lactate [52].”
BackgroundSerine Phosphorylation of Insulin Receptor Substrate 1 by Inhibitor κB Kinase Complex
Gao, Z., Hwang, D., Bataille, F., Lefevre, M., York, D., Quon, M. J., & Ye, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209459200 · Cited by 778
Nilwik, R., Snijders, T., Leenders, M., Groen, B. B. L., van Kranenburg, J., Verdijk, L. B., & van Loon, L. J. C. (2013) · Experimental Gerontology · doi:10.1016/j.exger.2013.02.012 · Cited by 776 · cited 1×
“In sarcopenic obesity, muscle is present as type II muscle fiber atrophy and increased lipid deposition and adipocytes [13,22].”
BackgroundZeng, G., Nystrom, F. H., Ravichandran, L. V., Cong, L.-N., Kirby, M., Mostowski, H., & Quon, M. J. (2000) · Circulation · doi:10.1161/01.cir.101.13.1539 · Cited by 745 · cited 1×
“Hyperinsulinemia due to IR impairs the IRS-1/PI3K/Akt pathway, which causes vasodilation by activating nitric oxide synthase (NOS) and leads to the production of nitric oxide (NO) [106].”
BackgroundProtein kinase C isozymes and the regulation of diverse cell responses
Dempsey, E. C., Newton, A. C., Mochly-Rosen, D., Fields, A. P., Reyland, M. E., Insel, P. A., & Messing, R. O. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.3.l429 · Cited by 737 · cited 1×
“PKC is a family of serine/threonine kinase activated by phospholipase C and hydrolysis of membrane phosphoinositides [78].”
BackgroundZhang, Y., Li, R., Meng, Y., Li, S., Donelan, W., Zhao, Y., Qi, L., Zhang, M., Wang, X., Cui, T., et al. (2014) · Diabetes · doi:10.2337/db13-1106 · Cited by 733 · cited 1×
“Irisin is a PPARγ-coactivator-1α (PGCα)-dependent myokine that stimulates browning in subcutaneous adipose tissues and induces increased energy expenditure, which improves obesity and IR through the MAPK and ERK pathways [92,93].”
BackgroundSkeletal muscle inflammation and insulin resistance in obesity
Wu, H., & Ballantyne, C. M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88880 · Cited by 695 · cited 1×
“The IKK/NF-kB pathway is activated by TNF-α, IL-1β, and free-fatty acids [62].”
BackgroundUeki, K., Kondo, T., & Kahn, C. R. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5434-5446.2004 · Cited by 686 · cited 8×
“This suppressing activity interferes with the crosstalk between the insulin receptor and IRS by inhibiting insulin receptor tyrosine kinase activity and degrading IRS [74,75].”
BackgroundInfluentialPathogenesis of insulin resistance in skeletal muscle
Abdul-Ghani, M. A., & DeFronzo, R. A. (2010) · Journal of Biomedicine and Biotechnology · doi:10.1155/2010/476279 · Cited by 670 · cited 1×
“Hence, impaired insulin signaling is commonly observed in sarcopenic obesity [10,11].”
BackgroundRegulation of metabolism by the innate immune system
Lackey, D. E., & Olefsky, J. M. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.189 · Cited by 667
Jiang, W., Wu, N., Wang, X., Chi, Y., Zhang, Y., Qiu, X., Hu, Y., Li, J., & Liu, Y. (2015) · Scientific Reports · doi:10.1038/srep08096 · Cited by 649 · cited 2×
“Recently, it was reported that NAFLD affects intestinal microbiota, resulting in decreased immune T-cells and increased proinflammatory markers, including TNF-α, IL-6, and IFN-γ [147].”
BackgroundPhosphorylation of IRS proteins, insulin action, and insulin resistance
Boura-Halfon, S., & Zick, Y. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90437.2008 · Cited by 598 · cited 1×
“In sarcopenic obesity, the increased lipid metabolites, such as including DAG and ceramides, activate serine/threonine kinases such as PKC, C-Jun NH2-terminal kinase (JNK), and IKK, resulting in the phosphorylation of serine/threonine in the insulin receptor protein and its substrates, resulting in impaired insulin si…”
BackgroundLim, S., Kim, J. H., Yoon, J. W., Kang, S. M., Choi, S. H., Park, Y. J., Kim, K. W., Lim, J. Y., Park, K. S., & Jang, H. C. (2010) · Diabetes Care · doi:10.2337/dc10-0107 · Cited by 588
Prevalence and Determinant Factors of Sarcopenia in Patients With Type 2 Diabetes
Kim, T. N., Park, M. S., Yang, S. J., Yoo, H. J., Kang, H. J., Song, W., Seo, J. A., Kim, S. G., Kim, N. H., Baik, S. H., et al. (2010) · Diabetes Care · doi:10.2337/dc09-2310 · Cited by 585 · cited 1×
“We also previously reported that patients with type 2 diabetes mellitus had higher BMI and a low appendicular skeletal mass and skeletal muscle index [132].”
BackgroundSelf-citationThe macrophage switch in obesity development
Castoldi, A., Naffah de Souza, C., Câmara, N. O. S., & Moraes-Vieira, P. M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00637 · Cited by 575 · cited 1×
“Macrophages also change the phenotype from M2 to M1, which releases proinflammatory molecules such as TNF-α, IL-1β, IL-6, and MCP-1/CCL2 [40,41].”
BackgroundNorheim, F., Langleite, T. M., Hjorth, M., Holen, T., Kielland, A., Stadheim, H. K., Gulseth, H. L., Birkeland, K. I., Jensen, J., & Drevon, C. A. (2014) · The FEBS Journal · doi:10.1111/febs.12619 · Cited by 563
Signaling pathways controlling skeletal muscle mass
Egerman, M. A., & Glass, D. J. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.857291 · Cited by 555 · cited 1×
“Low GH levels reduce IGF1 action by sequentially downregulating the PI3K-AKT/PKB-mTOR pathway, which induces protein synthesis in muscles [49].”
BackgroundThe Global Burden of Disease Study and the Preventable Burden of NCD
Benziger, C. P., Roth, G. A., & Moran, A. E. (2016) · Global Heart · doi:10.1016/j.gheart.2016.10.024 · Cited by 547 · cited 1×
“Among several risk factors, obesity, excess calorie intake, and low levels of physical activity are the main contributors [8], and insulin resistance (IR) is a common mechanism associated with the disease [9].”
BackgroundInsulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents
Di Pino, A., & DeFronzo, R. A. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00141 · Cited by 535 · cited 9×
“MAPK Family JNK is a member of the MAPK family and is activated by TNF-α, IL-1β, free-fatty acids, ER stress, and LTB4 [66,67].”
BackgroundInfluentialAtkins, J. L., Whincup, P. H., Morris, R. W., Lennon, L. T., Papacosta, O., & Wannamethee, S. G. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12652 · Cited by 509 · cited 1×
“A British regional health study reported that older subjects with sarcopenic obesity had the highest cardiovascular mortality [113].”
BackgroundPKC-θ knockout mice are protected from fat-induced insulin resistance
Kim, J. K., Fillmore, J. J., Sunshine, M. J., Albrecht, B., Higashimori, T., Kim, D.-W., Liu, Z.-X., Soos, T. J., Cline, G. W., O’Brien, W. R., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422230 · Cited by 500 · cited 1×
“Similar to IKK and JNK pathways, it induces serine or threonine phosphorylation or IR or IRS-1, resulting in impairment of insulin signaling [80,81].”
BackgroundInsulin resistance causes inflammation in adipose tissue
Shimobayashi, M., Albert, V., Woelnerhanssen, B., Frei, I. C., Weissenberger, D., Meyer-Gerspach, A. C., Clement, N., Moes, S., Colombi, M., Meier, J. A., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci96139 · Cited by 480 · cited 1×
“This activates the proinflammatory M1 macrophages which release cytokines such as TNF-α [109].”
BackgroundBiogenesis of the multifunctional lipid droplet: Lipids, proteins, and sites
Pol, A., Gross, S. P., & Parton, R. G. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201311051 · Cited by 466 · cited 1×
“IMCL predominantly comprises triacylglycerol; however, other lipid intermediates, such as diacylglycerol (DAG), long-chain acetyl coenzyme A, sterol esters, and sphingolipids, including ceramides, also exist [26,27].”
BackgroundRolland, Y., Lauwers-Cances, V., Cristini, C., van Kan, G. A., Janssen, I., Morley, J. E., & Vellas, B. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26950 · Cited by 465
Sarcopenic Obesity: The Confluence of Two Epidemics
Roubenoff, R. (2004) · Obesity Research · doi:10.1038/oby.2004.107 · Cited by 453 · cited 1×
“Reduced muscle mass synergistically accompanies accumulation of fat mass, resulting in sarcopenic obesity [3].”
BackgroundDavison, K. K., Ford, E. S., Cogswell, M. E., & Dietz, W. H. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50508.x · Cited by 435
Role of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans
Szendroedi, J., Yoshimura, T., Phielix, E., Koliaki, C., Marcucci, M., Zhang, D., Jelenik, T., Müller, J., Herder, C., Nowotny, P., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409229111 · Cited by 415 · cited 2×
“Similar to IKK and JNK pathways, it induces serine or threonine phosphorylation or IR or IRS-1, resulting in impairment of insulin signaling [80,81].”
BackgroundGuillet, C., Prod'homme, M., Balage, M., Gachon, P., Giraudet, C., Morin, L., Grizard, J., & Boirie, Y. (2004) · The FASEB Journal · doi:10.1096/fj.03-1341fje · Cited by 412
Kurdiova, T., Balaz, M., Vician, M., Maderova, D., Vlcek, M., Valkovic, L., Srbecky, M., Imrich, R., Kyselovicova, O., Belan, V., et al. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2013.264655 · Cited by 401 · cited 1×
“In human studies, the level of plasma irisin was positively associated with muscle mass and strength and negatively associated with the fasting glucose level [96].”
BackgroundKim, T. N., Yang, S. J., Yoo, H. J., Lim, K. I., Kang, H. J., Song, W., Seo, J. A., Kim, S. G., Kim, N. H., Baik, S. H., et al. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.130 · Cited by 401 · cited 1×
“Korea Sarcopenic Obesity Study [20] SMI < 7.”
BackgroundSelf-citationHong, H. C., Hwang, S. Y., Choi, H. Y., Yoo, H. J., Seo, J. A., Kim, S. G., Kim, N. H., Baik, S. H., Choi, D. S., & Choi, K. M. (2014) · Hepatology · doi:10.1002/hep.26716 · Cited by 385 · cited 7×
“Recently, it was reported that NAFLD affects intestinal microbiota, resulting in decreased immune T-cells and increased proinflammatory markers, including TNF-α, IL-6, and IFN-γ [147].”
BackgroundInfluentialSelf-citationDieli-Conwright, C. M., Courneya, K. S., Demark-Wahnefried, W., Sami, N., Lee, K., Buchanan, T. A., Spicer, D. V., Tripathy, D., Bernstein, L., & Mortimer, J. E. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.75.7526 · Cited by 366 · cited 1×
“In human studies, resistance and aerobic exercise improved sarcopenic obesity and increased the adiponectin levels in overweight or obese breast cancer survivors [102].”
BackgroundKim, J. K., Michael, M. D., Previs, S. F., Peroni, O. D., Mauvais-Jarvis, F., Neschen, S., Kahn, B. B., Kahn, C. R., & Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8305 · Cited by 331 · cited 1×
“In genetic mouse models of muscle-specific IR, by deleting the IRTK [142] or GLUT4 [143] genes, hepatic steatosis and adiposity were increased [142].”
BackgroundInflammation and metabolic cardiomyopathy
Nishida, K., & Otsu, K. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx012 · Cited by 329 · cited 1×
“Activated macrophages release TNF-α, IL-1b, IL-6, and TGF-β, which stimulate myofibroblasts, increase collagen production, and decrease protease inhibitor secretion [121,122].”
BackgroundRothman, D. L., Magnusson, I., Cline, G., Gerard, D., Kahn, C. R., Shulman, R. G., & Shulman, G. I. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.983 · Cited by 325 · cited 1×
“IR plays a major role in the pathogenesis of type 2 diabetes mellitus [128].”
BackgroundSkeletal muscle glycolysis, oxidation, and storage of an oral glucose load.
Kelley, D., Mitrakou, A., Marsh, H., Schwenk, F., Benn, J., Sonnenberg, G., Arcangeli, M., Aoki, T., Sorensen, J., & Berger, M. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113489 · Cited by 320
LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes
Li, P., Oh, D. Y., Bandyopadhyay, G., Lagakos, W. S., Talukdar, S., Osborn, O., Johnson, A., Chung, H., Mayoral, R., Maris, M., et al. (2015) · Nature Medicine · doi:10.1038/nm.3800 · Cited by 315 · cited 2×
“JNK is a member of the MAPK family and is activated by TNF-α, IL-1β, free-fatty acids, ER stress, and LTB4 [66,67].”
BackgroundThe disposal of an oral glucose load in patients with non-insulin-dependent diabetes
Ferrannini, E., Simonson, D. C., Katz, L. D., Reichard, G., Bevilacqua, S., Barrett, E. J., Olsson, M., & DeFronzo, R. A. (1988) · Metabolism · doi:10.1016/0026-0495(88)90033-9 · Cited by 305 · cited 1×
“Even though pancreatic beta cell dysfunction is the main pathogenesis of type 2 diabetes mellitus, given that the uptake of postprandial glucose by skeletal muscles is approximately 80–90%, skeletal muscle IR plays a crucial role in the development and progression of diabetes mellitus [129,130].”
BackgroundHealth Consequences of Sarcopenic Obesity: A Narrative Review
Roh, E., & Choi, K. M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00332 · Cited by 304
Self-citationMediterranean diet nutrients to turn the tide against insulin resistance and related diseases
Mirabelli, M., Chiefari, E., Arcidiacono, B., Corigliano, D. M., Brunetti, F. S., Maggisano, V., Russo, D., Foti, D. P., & Brunetti, A. (2020) · Nutrients · doi:10.3390/nu12041066 · Cited by 272
Grootaert, M. O., da Costa Martins, P. A., Bitsch, N., Pintelon, I., De Meyer, G. R., Martinet, W., & Schrijvers, D. M. (2015) · Autophagy · doi:10.1080/15548627.2015.1096485 · Cited by 267 · cited 1×
“Atherosclerotic plaque rupture can lead to myocardial infarction and stroke [105].”
BackgroundKraakman, M. J., Kammoun, H. L., Allen, T. L., Deswaerte, V., Henstridge, D. C., Estevez, E., Matthews, V. B., Neill, B., White, D. A., Murphy, A. J., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.02.006 · Cited by 257 · cited 1×
“recruits macrophages in the adipose tissue [86].”
Neural control of aging skeletal muscle
Delbono, O. (2003) · Aging Cell · doi:10.1046/j.1474-9728.2003.00011.x · Cited by 248
Implication of inflammatory signaling pathways in obesity-induced insulin resistance
Tanti, J.-F., Ceppo, F., Jager, J., & Berthou, F. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00181 · Cited by 239
Abdulnour, J., Doucet, É., Brochu, M., Lavoie, J.-M., Strychar, I., Rabasa-Lhoret, R., & Prud’homme, D. (2012) · Menopause · doi:10.1097/gme.0b013e318240f6f3 · Cited by 229 · cited 1×
“In menopausal women, decreased levels of estrogen and increased levels of follicle-stimulating hormone and androgen resulted in increased deposition of visceral adipose tissues and decreased fat-free mass, leading to sarcopenic obesity [48].”
BackgroundThe implications of sarcopenia and sarcopenic obesity on cardiometabolic disease
Kim, T. N., & Choi, K. M. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25077 · Cited by 225 · cited 1×
“These results suggest that sarcopenic obesity mediated IR accompanies vascular smooth muscle growth and vascular endothelial damage by chronic inflammation and oxidative stress, leading to atherosclerosis and cardiovascular disease [114].”
BackgroundSelf-citationFujita, S., Rasmussen, B. B., Cadenas, J. G., Drummond, M. J., Glynn, E. L., Sattler, F. R., & Volpi, E. (2007) · Diabetes · doi:10.2337/db06-1566 · Cited by 224
IL-6 selectively stimulates fat metabolism in human skeletal muscle
Wolsk, E., Mygind, H., Grøndahl, T. S., Pedersen, B. K., & van Hall, G. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00328.2010 · Cited by 221 · cited 1×
“Acute increment of IL-6 in healthy humans in association with classic signaling, improved insulin sensitivity by enhancing glucose uptake, and increased fatty acid oxidation in myocytes [84].”
BackgroundMorris, D. L., Cho, K. W., DelProposto, J. L., Oatmen, K. E., Geletka, L. M., Martinez-Santibanez, G., Singer, K., & Lumeng, C. N. (2013) · Diabetes · doi:10.2337/db12-1404 · Cited by 217 · cited 1×
“The infiltrated macrophages in muscle tissue present adipocyte-derived antigens and activate antigen-specific CD4+ T cells [39].”
BackgroundZhang, X., Xie, X., Dou, Q., Liu, C., Zhang, W., Yang, Y., Deng, R., & Cheng, A. S. K. (2019) · BMC Geriatrics · doi:10.1186/s12877-019-1195-y · Cited by 209
Resistance exercise induces a greater irisin response than endurance exercise
Tsuchiya, Y., Ando, D., Takamatsu, K., & Goto, K. (2015) · Metabolism · doi:10.1016/j.metabol.2015.05.010 · Cited by 207
Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4
Kim, J. K., Zisman, A., Fillmore, J. J., Peroni, O. D., Kotani, K., Perret, P., Zong, H., Dong, J., Kahn, C. R., Kahn, B. B., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10294 · Cited by 202 · cited 8×
“In genetic mouse models of muscle-specific IR, by deleting the IRTK [142] or GLUT4 [143] genes, hepatic steatosis and adiposity were increased [142].”
BackgroundInfluentialKadi, F. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.118 · Cited by 200 · cited 1×
“Testosterone is an anabolic hormone that simulates protein synthesis by increasing amino acid utilization, and it also increases androgen receptor expression in skeletal muscle cells [45].”
BackgroundKim, G., Lee, S., Lee, Y., Jun, J. E., Ahn, J., Bae, J. C., Jin, S., Hur, K. Y., Jee, J. H., Lee, M., et al. (2018) · Hepatology · doi:10.1002/hep.30049 · Cited by 198 · cited 1×
“In a longitudinal cohort, subjects with sarcopenia were shown to have a higher risk of NAFLD and increased skeletal muscle index resolute [148].”
BackgroundTargeting fatty acid metabolism to improve glucose metabolism
Stinkens, R., Goossens, G. H., Jocken, J. W. E., & Blaak, E. E. (2015) · Obesity Reviews · doi:10.1111/obr.12298 · Cited by 183 · cited 1×
“Mitochondrial dysfunction results in further intracellular fatty acid ambulation, creating a vicious cycle of lipotoxicity [58].”
BackgroundJové, M., Planavila, A., Sánchez, R. M., Merlos, M., Laguna, J. C., & Vázquez-Carrera, M. (2006) · Endocrinology · doi:10.1210/en.2005-0440 · Cited by 172
Differential role of insulin/IGF-1 receptor signaling in muscle growth and glucose homeostasis
O’Neill, B. T., Lauritzen, H. P. M. M., Hirshman, M. F., Smyth, G., Goodyear, L. J., & Kahn, C. R. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.037 · Cited by 171
cJun NH2-terminal kinase 1 (JNK1): Roles in metabolic regulation of insulin resistance
Sabio, G., & Davis, R. J. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.04.004 · Cited by 170 · cited 1×
“JNK causes IR by inducing serine and threonine phosphorylation of IRS and attenuating downstream insulin signaling [68].”
BackgroundBowen, T. S., Rolim, N. P. L., Fischer, T., Bækkerud, F. H., Medeiros, A., Werner, S., Brønstad, E., Rognmo, O., Mangner, N., Linke, A., et al. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.239 · Cited by 165 · cited 1×
“In rats with heart failure, pro-oxidants such as NADPH oxidase and XO activity were higher, and antioxidants, such as catalase and superoxide dismutase (SOD), were lower than in corresponding controls [124].”
BackgroundFischer, C. P., Plomgaard, P., Hansen, A. K., Pilegaard, H., Saltin, B., & Pedersen, B. K. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00206.2004 · Cited by 165 · cited 1×
“As a myokine, IL-6 releases from the skeletal muscle in condition of acute muscle contraction without damage [83].”
BackgroundBellanti, F., Romano, A. D., Lo Buglio, A., Castriotta, V., Guglielmi, G., Greco, A., Serviddio, G., & Vendemiale, G. (2018) · Maturitas · doi:10.1016/j.maturitas.2017.12.002 · Cited by 158 · cited 1×
“In a clinical study, patients with sarcopenic obesity had higher carotid intima-media thickness (IMT) and oxidative stress markers compared to sarcopenic non-obese and/or non-sarcopenic patients [111].”
BackgroundSarcopenic obesity: molecular clues to a better understanding of its pathogenesis?
Kob, R., Bollheimer, L. C., Bertsch, T., Fellner, C., Djukic, M., Sieber, C. C., & Fischer, B. E. (2015) · Biogerontology · doi:10.1007/s10522-014-9539-7 · Cited by 151 · cited 1×
“These cytokines induce muscle atrophy by increasing apoptosis and upregulating proteosomal decay of filament proteins [42].”
BackgroundBosma, M., Sparks, L. M., Hooiveld, G. J. E. J., Jörgensen, J. A., Houten, S. M., Schrauwen, P., Kersten, S., & Hesselink, M. K. C. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.01.007 · Cited by 149 · cited 2×
“Overexpression of PLIN5 in skeletal muscle increases the gene expression involving fatty acid oxidation mediating PPARα and PGC1α [33].”
BackgroundScott, D., Chandrasekara, S. D., Laslett, L. L., Cicuttini, F., Ebeling, P. R., & Jones, G. (2016) · Calcified Tissue International · doi:10.1007/s00223-016-0123-9 · Cited by 149
Kimball, S. R., Horetsky, R. L., & Jefferson, L. S. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.274.1.c221 · Cited by 148
Abbenhardt, C., McTiernan, A., Alfano, C. M., Wener, M. H., Campbell, K. L., Duggan, C., Foster‐Schubert, K. E., Kong, A., Toriola, A. T., Potter, J. D., et al. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12062 · Cited by 137
Skeletal muscle wasting in chronic heart failure
Suzuki, T., Palus, S., & Springer, J. (2018) · ESC Heart Failure · doi:10.1002/ehf2.12387 · Cited by 134 · cited 1×
“In a clinical study, patients with sarcopenia and/or obesity had a higher risk of co-morbidity and poor prognosis with chronic heart failure [125].”
BackgroundRivas, D. A., McDonald, D. J., Rice, N. P., Haran, P. H., Dolnikowski, G. G., & Fielding, R. A. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00198.2015 · Cited by 132 · cited 1×
“Intermyocellular adipose tissue (IMAT) and IMCL secrete myostatin, CCL2, TNF-α, IL-1β, and IL-6, thus inducing IR and lipotoxicity, which is discussed in the next section [30].”
BackgroundIs interleukin-1β a culprit in macrophage-adipocyte crosstalk in obesity?
Bing, C. (2015) · Adipocyte · doi:10.4161/21623945.2014.979661 · Cited by 127 · cited 1×
“Macrophages also change the phenotype from M2 to M1, which releases proinflammatory molecules such as TNF-α, IL-1β, IL-6, and MCP-1/CCL2 [40,41].”
BackgroundMashili, F., Chibalin, A. V., Krook, A., & Zierath, J. R. (2013) · Diabetes · doi:10.2337/db12-0337 · Cited by 125 · cited 1×
“It is not fully understood how the JAK-STAT pathway leads to IR in muscle tissues, and controversial results from previous studies have suggested that muscle-specific STAT3 in mice does not alter IR [72,73].”
BackgroundPatsouris, D., Cao, J.-J., Vial, G., Bravard, A., Lefai, E., Durand, A., Durand, C., Chauvin, M.-A., Laugerette, F., Debard, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110653 · Cited by 122 · cited 1×
“While a report shows that local inflammation induced by muscle MCP-1 overexpression interferes with insulin signaling in muscle [60], the other study does not report a similar observation [61].”
BackgroundOvernutrition, mTOR signaling, and cardiovascular diseases
Jia, G., Aroor, A. R., Martinez-Lemus, L. A., & Sowers, J. R. (2014) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00262.2014 · Cited by 122
Natalicchio, A., Marrano, N., Biondi, G., Spagnuolo, R., Labarbuta, R., Porreca, I., Cignarelli, A., Bugliani, M., Marchetti, P., Perrini, S., et al. (2017) · Diabetes · doi:10.2337/db17-0002 · Cited by 121 · cited 1×
“Irisin also stimulates beta-cell survival and glucose-stimulated insulin secretion through the PGA pathway, and inhibits saturated fatty acid-induced apoptosis in pancreatic beta-cells [94].”
BackgroundLee, J., Hong, Y.-P., Shin, H. J., & Lee, W. (2015) · Journal of Preventive Medicine and Public Health · doi:10.3961/jpmph.15.055 · Cited by 119
Modulation of glucose metabolism by the renin-angiotensin-aldosterone system
Favre, G. A., Esnault, V. L. M., & Van Obberghen, E. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00391.2014 · Cited by 114
Brøns, C., & Grunnet, L. G. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0488 · Cited by 110 · cited 1×
“IMCL predominantly comprises triacylglycerol; however, other lipid intermediates, such as diacylglycerol (DAG), long-chain acetyl coenzyme A, sterol esters, and sphingolipids, including ceramides, also exist [26,27].”
BackgroundInsulin Resistance and Risk of Incident Heart Failure: Cardiovascular Health Study
Banerjee, D., Biggs, M. L., Mercer, L., Mukamal, K., Kaplan, R., Barzilay, J., Kuller, L., Kizer, J. R., Djousse, L., Tracy, R., et al. (2013) · Circulation: Heart Failure · doi:10.1161/circheartfailure.112.000022 · Cited by 105 · cited 1×
“Even in subjects without heart failure, myocardial infarction, and diabetes mellitus, fasting plasma insulin level was positively associated with adverse echocardiographic features, which predispose them to a risk of heart failure [126].”
BackgroundTalbot, N. A., Wheeler-Jones, C. P., & Cleasby, M. E. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.06.010 · Cited by 104 · cited 1×
“Activated p38 MAPK is also involved in muscle IR [69].”
BackgroundAging- and obesity-related peri-muscular adipose tissue accelerates muscle atrophy
Zhu, S., Tian, Z., Torigoe, D., Zhao, J., Xie, P., Sugizaki, T., Sato, M., Horiguchi, H., Terada, K., Kadomatsu, T., et al. (2019) · PLOS ONE · doi:10.1371/journal.pone.0221366 · Cited by 100 · cited 1×
“The amount of PMAT is correlated with the severity of muscle atrophy [31].”
BackgroundKitessa, S., & Abeywardena, M. (2016) · Nutrients · doi:10.3390/nu8080466 · Cited by 98 · cited 1×
“Activated macrophages release TNF-α, IL-1b, IL-6, and TGF-β, which stimulate myofibroblasts, increase collagen production, and decrease protease inhibitor secretion [121,122].”
BackgroundAdiponectin resistance in skeletal muscle: Pathophysiological implications in chronic heart failure
Sente, T., Van Berendoncks, A. M., Hoymans, V. Y., & Vrints, C. J. (2016) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12086 · Cited by 95 · cited 1×
“Furthermore, patients with chronic heart failure showed adiponectin resistance in myocardial and skeletal muscle cells through increased oxidative stress [127].”
BackgroundHafizi Abu Bakar, M., Kian Kai, C., Wan Hassan, W. N., Sarmidi, M. R., Yaakob, H., & Zaman Huri, H. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2601 · Cited by 91 · cited 2×
“IR correlates with impaired lipid oxidation in the mitochondria [57].”
BackgroundLipid droplet dynamics in skeletal muscle
Bosma, M. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.10.023 · Cited by 91 · cited 1×
“Ablation of PLIN5 results in reduced TAG storage, but increased sphingolipids such as ceramide and sphingomyelin, thus leading to IR in the skeletal muscle [36].”
BackgroundDynapenic obesity and the risk of incident Type 2 diabetes: the english longitudinal study of ageing
Cuthbertson, D. J., Bell, J. A., Ng, S. Y., Kemp, G. J., Kivimaki, M., & Hamer, M. (2016) · Diabetic Medicine · doi:10.1111/dme.12991 · Cited by 86 · cited 1×
“In a clinical study, patients with sarcopenic obesity with higher BMI and lower hand grip strength had a higher risk of type 2 diabetes mellitus than controls did [131].”
BackgroundComparisons of three different methods for defining sarcopenia: an aspect of cardiometabolic risk
Kim, T. N., Park, M. S., Lee, E. J., Chung, H. S., Yoo, H. J., Kang, H. J., Song, W., Baik, S. H., & Choi, K. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-06831-7 · Cited by 86
Self-citationMcKay, B. R., Ogborn, D. I., Baker, J. M., Toth, K. G., Tarnopolsky, M. A., & Parise, G. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00305.2012 · Cited by 83 · cited 3×
“In mice, macrophage-specific ablation of SOCS1 increases systemic inflammation and IR [76], and a loss of function of the cavin-1 binding sites on SOCS3 consequently induces lipodystrophy and IR in mice [77].”
BackgroundBuechler, C., Haberl, E., Rein-Fischboeck, L., & Aslanidis, C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071392 · Cited by 83 · cited 1×
“Decreased adiponectin levels are also noted in advanced hepatic injury [145].”
BackgroundSachithanandan, N., Graham, K. L., Galic, S., Honeyman, J. E., Fynch, S. L., Hewitt, K. A., Steinberg, G. R., & Kay, T. W. (2011) · Diabetes · doi:10.2337/db11-0259 · Cited by 81 · cited 1×
“In mice, macrophage-specific ablation of SOCS1 increases systemic inflammation and IR [76], and a loss of function of the cavin-1 binding sites on SOCS3 consequently induces lipodystrophy and IR in mice [77].”
BackgroundPeters, S. J., Samjoo, I. A., Devries, M. C., Stevic, I., Robertshaw, H. A., & Tarnopolsky, M. A. (2012) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h2012-059 · Cited by 81 · cited 1×
“The perilipin family of proteins (PLIN) is embedded in lipid droplets, and functions as a regulator of skeletal muscle lipid metabolism and mitochondrial oxidation [32,33].”
BackgroundEffects of testosterone on body composition of the aging male
Mudali, S. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.01.004 · Cited by 77 · cited 1×
“Hypogonadal status also contributes to sarcopenic obesity by increasing levels of TNF-α and IL-6, which leads to central obesity [11,47].”
BackgroundMichalska, M., Bielecka-Dabrowa, A. M., von Haehling, S., Anker, S. D., Rysz, J., & Banach, M. (2018) · Archives of Medical Science · doi:10.5114/aoms.2018.76279 · Cited by 77 · cited 1×
“As a result, the extracellular matrix is degraded by Smad-dependent and/or independent signaling pathways and fibrosis occurs in both cardiac and skeletal muscles [123].”
BackgroundGannon, J., Doran, P., Kirwan, A., & Ohlendieck, K. (2009) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2009.06.004 · Cited by 74 · cited 1×
“resulting in decreased muscle mass and strength [23].”
BackgroundHarper (2016) · doi:10.1161/circresaha.116.307962 · Cited by 74
Nettleship, J., Pugh, P., Channer, K., Jones, T., & Jones, R. (2007) · Hormone and Metabolic Research · doi:10.1055/s-2007-976543 · Cited by 73
Kang, S.-Y., Lim, G. E., Kim, Y. K., Kim, H. W., Lee, K., Park, T.-J., & Kim, J. (2017) · Journal of Bone Metabolism · doi:10.11005/jbm.2017.24.1.9 · Cited by 69
Harris, L.-A. L. S., Skinner, J. R., Shew, T. M., Pietka, T. A., Abumrad, N. A., & Wolins, N. E. (2015) · Diabetes · doi:10.2337/db14-1035 · Cited by 68
Mid-adulthood cardiometabolic risk factor profiles of sarcopenic obesity
Ma, J., Hwang, S., McMahon, G. M., Curhan, G. C., Mclean, R. R., Murabito, J. M., & Fox, C. S. (2016) · Obesity · doi:10.1002/oby.21356 · Cited by 68
Forti, L. N., Njemini, R., Beyer, I., Eelbode, E., Meeusen, R., Mets, T., & Bautmans, I. (2014) · AGE · doi:10.1007/s11357-014-9704-6 · Cited by 67
Henstridge, D. C., Bruce, C. R., Pang, C. P., Lancaster, G. I., Allen, T. L., Estevez, E., Gardner, T., Weir, J. M., Meikle, P. J., Lam, K. S. L., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2652-8 · Cited by 67 · cited 2×
“JNK is a member of the MAPK family and is activated by TNF-α, IL-1β, free-fatty acids, ER stress, and LTB4 [66,67].”
BackgroundMitochondrial involvement in skeletal muscle insulin resistance: A case of imbalanced bioenergetics
Affourtit, C. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.07.008 · Cited by 67 · cited 1×
“This then results in the inhibition of mitochondrial respiration, increase in ROS formation, myocyte toxicity, and finally, development of sarcopenia [29].”
BackgroundKim, Y., White, T., Wijndaele, K., Sharp, S. J., Wareham, N. J., & Brage, S. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.122 · Cited by 66
Adipokines and Myokines: A Pivotal Role in Metabolic and Cardiovascular Disorders
Chung, H. S., & Choi, K. M. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666171205144627 · Cited by 65 · cited 2×
“Adiponectin also decreases inflammation by inhibiting TNF-α and IL-γ secretion and elevating IL-10 and IL-1 receptor antagonist production from monocytes and macrophages [82].”
BackgroundSelf-citationScott, D., Cumming, R., Naganathan, V., Blyth, F., Le Couteur, D. G., Handelsman, D. J., Seibel, M., Waite, L. M., & Hirani, V. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.04.006 · Cited by 65 · cited 1×
“However, in an Australian study assessing older men, sarcopenic obesity was associated with metabolic syndrome; however, obesity itself, rather than the sarcopenia measured by ALM, grip strength, or gait speed was more predictive of metabolic syndrome [139].”
BackgroundIntramyocellular lipid droplets and insulin sensitivity, the human perspective
Gemmink, A., Goodpaster, B. H., Schrauwen, P., & Hesselink, M. K. C. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.07.010 · Cited by 62
Korytowski, W., Wawak, K., Pabisz, P., Schmitt, J. C., Chadwick, A. C., Sahoo, D., & Girotti, A. W. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.115.306210 · Cited by 49 · cited 2×
“When macrophages are under oxidative stress, oxidized lipids such as 7-hydroperoxide proceed to inactivate CYP27A1, reducing ABCA1/G1 expression and ultimately leading to impaired cholesterol efflux to the extracellular apoA-I or HDL [110].”
BackgroundYu, Y., Wei, S., Zhang, Z.-H., Weiss, R. M., & Felder, R. B. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00703.2015 · Cited by 46 · cited 1×
“RAS activity in brain paraventricular nucleus upregulates MAPK signaling and results in sympathetic excitation in rats with heart failure [119].”
BackgroundFitzgibbons, T. P., & Czech, M. P. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1385-4 · Cited by 45 · cited 2×
“However, macrophages regulate inflammation in adipose tissue, and have autophagic functions whereby they prevent proinflammatory M1 macrophage-polarization by delivering cytoplasmic contents to lysosomes to degrade them and promote homeostasis through an mTOR activation process [44].”
BackgroundCHO, K.-A., & KANG, P. B. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2276 · Cited by 43 · cited 1×
“In cultured myocytes, a lipid droplet-associated protein perilipin 2 increases expression of NLRP3 inflammasome, resulting in impaired insulin-stimulated glucose uptake [37].”
BackgroundSarcopenia and non-alcoholic fatty liver disease: Is there a relationship? A systematic review
Tovo, C. V., Fernandes, S. A., Buss, C., & de Mattos, A. A. (2017) · World Journal of Hepatology · doi:10.4254/wjh.v9.i6.326 · Cited by 42
Sente, T., Van Berendoncks, A. M., Fransen, E., Vrints, C. J., & Hoymans, V. Y. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00831.2015 · Cited by 41 · cited 1×
“In contrast, TNF-α impairs adiponectin signaling, mitochondrial biogenesis, and oxidative capacity, resulting in impaired functionality of skeletal muscles [101].”
BackgroundConte, M., Vasuri, F., Bertaggia, E., Armani, A., Santoro, A., Bellavista, E., Degiovanni, A., D’Errico, A., Trisolino, G., Capri, M., et al. (2015) · Biogerontology · doi:10.1007/s10522-014-9549-5 · Cited by 36 · cited 1×
“PLIN comprises PLIN1 to PLIN5, and PLIN2 and PLIN 5 are predominantly found in muscle tissue [34,35].”
BackgroundTriglycerides Potentiate the Inflammatory Response in Rat Kupffer Cells
Budick-Harmelin, N., Dudas, J., Demuth, J., Madar, Z., Ramadori, G., & Tirosh, O. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1876 · Cited by 35 · cited 1×
“When hepatocyte injury occurs, oxidative stress activates Kupffer cells, which release TNF-α and IL-6, leading to chronic inflammation and liver fibrogenesis progression [146].”
BackgroundWilliams, J. J. L., Alotaiq, N., Mullen, W., Burchmore, R., Liu, L., Baillie, G. S., Schaper, F., Pilch, P. F., & Palmer, T. M. (2018) · Nature Communications · doi:10.1038/s41467-017-02585-y · Cited by 35
Zhou, X., Li, R., Liu, X., Wang, L., Hui, P., Chan, L., Saha, P. K., & Hu, Z. (2016) · Scientific Reports · doi:10.1038/srep29669 · Cited by 35 · cited 1×
“A low level of irisin in mice with muscle-specific constitutive ROCK1 activation suppresses irisin production in muscles, decreasing browning in adipocytes and leading to impaired insulin sensitivity [95].”
BackgroundYamashita, M., Kamiya, K., Matsunaga, A., Kitamura, T., Hamazaki, N., Matsuzawa, R., Nozaki, K., Tanaka, S., Nakamura, T., Maekawa, E., et al. (2019) · Journal of Cardiology · doi:10.1016/j.jjcc.2019.02.010 · Cited by 34 · cited 1×
“These factors result in increasing frailty and an increased risk of mortality [2,12].”
BackgroundEvers-van Gogh, I. J. A., Oteng, A.-B., Alex, S., Hamers, N., Catoire, M., Stienstra, R., Kalkhoven, E., & Kersten, S. (2016) · Diabetologia · doi:10.1007/s00125-015-3822-2 · Cited by 33 · cited 1×
“While a report shows that local inflammation induced by muscle MCP-1 overexpression interferes with insulin signaling in muscle [60], the other study does not report a similar observation [61].”
BackgroundLangkilde, A., Petersen, J., Henriksen, J. H., Jensen, F. K., Gerstoft, J., Eugen‐Olsen, J., & Andersen, O. (2015) · Immunity & Ageing · doi:10.1186/s12979-015-0036-x · Cited by 33 · cited 3×
“In mice, macrophage-specific ablation of SOCS1 increases systemic inflammation and IR [76], and a loss of function of the cavin-1 binding sites on SOCS3 consequently induces lipodystrophy and IR in mice [77].”
BackgroundNonalcoholic fatty liver disease in the over-60s: Impact of sarcopenia and obesity
Wijarnpreecha, K., Panjawatanan, P., Aby, E., Ahmed, A., & Kim, D. (2019) · Maturitas · doi:10.1016/j.maturitas.2019.03.016 · Cited by 32 · cited 2×
“Several cross-sectional studies have shown an association between sarcopenia and/or obesity and NAFD [144,149].”
BackgroundKuo, Y.-K., Lin, Y., Lee, C., Chen, C., Tani, J., Huang, T., Chang, H. C., & Wu, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21083010 · Cited by 32
Overproduction of altered VLDL in an insulin-resistance rat model: Influence of SREBP-1c and PPAR-α
Lucero, D., Miksztowicz, V., Macri, E. V., López, G. H., Friedman, S., Berg, G. A., Zago, V., & Schreier, L. E. (2015) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2014.11.002 · Cited by 29 · cited 1×
“IR also activates SREBP-1c and inhibits acetyl-coenzyme A carboxylase, leading to reduced PPAR-a expression and the promotion of large-sized and TG-rich VLDL synthesis and secretion [135].”
BackgroundPuz, P., & Lasek–Bal, A. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.06.008 · Cited by 27
Vijayvargia, R., Mann, K., Weiss, H. R., Pownall, H. J., & Ruan, H. (2010) · Obesity · doi:10.1038/oby.2009.501 · Cited by 25 · cited 1×
“Palmitate-induced IR in myocytes shows increase in JNK activity and knockdown of JNK in mice, which shows alleviated IR by enhanced fatty acid utilization and glucose oxidation [70,71].”
BackgroundBallak, D. B., van Essen, P., van Diepen, J. A., Jansen, H., Hijmans, A., Matsuguchi, T., Sparrer, H., Tack, C. J., Netea, M. G., Joosten, L. A. B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089615 · Cited by 20 · cited 1×
“Chronically elevated IL-6 levels increase MAP3K8 expression in adipose tissue, which is a signal transducer that regulates activation of NF-kB and JNK transcription factors and leads to IR [89].”
BackgroundGruzdeva, O., Uchasova, E., Dyleva, Y., Akbasheva, O., Matveeva, V., Karetnikova, V., Kokov, A., & Barbarash, O. (2017) · BMC Cardiovascular Disorders · doi:10.1186/s12872-017-0473-x · Cited by 13 · cited 1×
“Among patients with myocardial infarction, those with visceral obesity had elevated levels of proinflammatory cytokines, such as TNF-α, IL-1b, IL-6, IL-8, IL-12, and CRP than those without visceral obesity [112].”
BackgroundMineralocorticoid receptor antagonists for the treatment of hypertension and the metabolic syndrome
Pitt, B. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.04117 · Cited by 9 · cited 1×
“The mTOR-S6K1 pathway increases the expression of epithelial sodium channels in the vascular cell membrane and activates serum-and-glucocorticoid-regulated kinase 1, which leads to reduced NO production and increased cardiac stiffness [117].”
BackgroundSenn, J. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.a109.513304 · Cited by 8 · cited 1×
“Palmitate-induced IR in myocytes shows increase in JNK activity and knockdown of JNK in mice, which shows alleviated IR by enhanced fatty acid utilization and glucose oxidation [70,71].”
BackgroundChoi, K. M., Hwang, S. Y., Han, K., Chung, H. S., Kim, N. H., Yoo, H. J., Seo, J. A., Kim, S. G., Kim, N. H., Baik, S. H., et al. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01417-3 · Cited by 3
Self-citation
Research works printed but not linked: 1
- White, 2013, Knockout of STAT3 in skeletal muscle does not enhance insulin action, Diabetologia, 56, S250
Cited by
Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement
Donini, L. M., Busetto, L., Bischoff, S. C., Cederholm, T., Ballesteros-Pomar, M. D., Batsis, J. A., Bauer, J. M., Boirie, Y., Cruz-Jentoft, A. J., Dicker, D., et al. (2022) · Obesity Facts · doi:10.1159/000521241 · Cited by 1,019
The crucial role and mechanism of insulin resistance in metabolic disease
Zhao, X., An, X., Yang, C., Sun, W., Ji, H., & Lian, F. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1149239 · Cited by 557
Tanase, D. M., Gosav, E. M., Costea, C. F., Ciocoiu, M., Lacatusu, C. M., Maranduca, M. A., Ouatu, A., & Floria, M. (2020) · Journal of Diabetes Research · doi:10.1155/2020/3920196 · Cited by 627
“Hence, IR and inflammation form a vicious circle, each condition promoting the other and accelerating the development of NAFLD and other metabolic disorders in the presence of lipotoxicity [107].”
BackgroundPathogenesis of sarcopenia and the relationship with fat mass: descriptive review
Li, C., Yu, K., Shyh‐Chang, N., Jiang, Z., Liu, T., Ma, S., Luo, L., Guang, L., Liang, K., Ma, W., et al. (2022) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12901 · Cited by 626
“obesity, is the concurrence of muscle loss and excessive body fat accrual.([59]) The definition of SO has not been universally”
BackgroundDefinition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement
Donini, L. M., Busetto, L., Bischoff, S. C., Cederholm, T., Ballesteros-Pomar, M. D., Batsis, J. A., Bauer, J. M., Boirie, Y., Cruz-Jentoft, A. J., Dicker, D., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2021.11.014 · Cited by 566
“Obesity can independently lead to loss of muscle mass and function, due to the negative impact of adipose tissue-depen-dent metabolic derangements, such as oxidative stress, inflammation and insulin resistance, all of which negatively affect muscle mass [6].”
Metadata
- Authors
- Hong, S.-H., & Choi, K. M.
- Affiliations
- Korea University (KR)
- Corresponding author
- Choi, Kyung Mook
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-01-13
- Volume
- 21
- Issue
- 2
- Pages
- 494
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7013734
- OpenAlex
- W2999215393
- Cited by
- 390
- References
- 153
- Citations by year
- 2026: 91 · 2025: 87 · 2024: 68 · 2023: 72 · 2022: 40 · 2021: 20 · 2020: 11
- FWCI
- 4.59
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Korea Christian University (Q1625561)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- sarcopenic obesity, insulin resistance, cardiometabolic disease, type 2 diabetes, non-alcoholic fatty liver disease, cardiovascular disease, muscle atrophy, mitochondrial dysfunction, oxidative stress, myokines, adipokines, insulin signaling, aging
- MeSH terms
- Animals, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Mitochondria, Liver, Mitochondria, Muscle, Obesity, Sarcopenia, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.